Disease Overview：Polyneuropathy（PNP）
Polyneuropathy refers to a heterogeneous group of disorders characterized by simultaneous dysfunction of multiple peripheral nerves, often presenting with symmetrical sensory disturbances (e.g., numbness, paresthesia), motor weakness, and autonomic symptoms. Etiologies include metabolic conditions (notably diabetes mellitus), autoimmune mechanisms (e.g., chronic inflammatory demyelinating polyneuropathy—CIDP), toxic exposures, hereditary neuropathies (e.g., Charcot–Marie–Tooth disease), and paraneoplastic syndromes. Diagnosis relies on comprehensive clinical evaluation, nerve conduction studies, electromyography, serum biomarker testing, and occasionally nerve or skin biopsy. Management is etiology-specific: immunomodulatory therapies (IVIG, corticosteroids, plasma exchange) for inflammatory forms; strict glycemic control in diabetic neuropathy; vitamin supplementation in deficiency-related cases; and symptomatic relief via neuropathic agents (e.g., gabapentin, duloxetine). Early intervention significantly influences functional preservation and quality of life.
China offers distinct advantages for international patients seeking polyneuropathy care. Leading neurology centers—such as Beijing Union Medical College Hospital and Shanghai Huashan Hospital—house nationally certified Neuromuscular Disease Units staffed by specialists trained in both Western and integrative neurology. Advanced diagnostic capabilities include high-resolution nerve ultrasound, next-generation sequencing for genetic subtyping, and quantitative sensory testing. Clinical outcomes align with international benchmarks: over 78% of CIDP patients achieve sustained remission with protocol-driven IVIG regimens, and multidisciplinary rehabilitation programs demonstrate measurable improvements in gait stability and daily function. Treatment costs remain substantially lower than in the US or Western Europe—typically 40–60% less for comparable diagnostics and biologic therapies—without compromising evidence-based standards.
As a dedicated medical tourism agency, we facilitate seamless access to these resources: coordinating appointments with certified neurologists, verifying hospital accreditation, providing itemized, transparent pricing in advance, and delivering end-to-end support—from visa assistance and medical translation to post-treatment follow-up coordination.
Polyneuropathy: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Polyneuropathy (Neurology Department)
Non-Surgical / Conservative / Medication-Based Management
*Target criteria:* Mild-to-moderate idiopathic, diabetic, or immune-mediated polyneuropathy without acute motor failure or autonomic crisis.
- •First-line pharmacotherapy
- Pregabalin (75–300 mg/day): ¥180–¥360/month ($25–$50) - Duloxetine (60 mg/day): ¥220–¥320/month ($31–$45)
- •Disease-modifying therapy (immune-mediated)
- Oral corticosteroids (prednisone taper): ¥30–¥90/course ($4–$13)
- •Diagnostic & monitoring exams (per episode)
- Serum glucose/HbA1c, vitamin B12, folate, SPEP/IFE, ANA/ENA: ¥320–¥580 ($45–$81) - CSF analysis (if suspected inflammatory cause): ¥650–¥950 ($91–$133)
Surgical / Procedural / Interventional Options
*Eligibility criteria:* Confirmed compressive mononeuropathy superimposed on polyneuropathy (e.g., carpal tunnel syndrome exacerbating distal symmetric neuropathy), or rare cases ofathy requiring tumor resection. *No neurosurgical intervention targets polyneuropathy itself.*
- •Carpal tunnel release (open or endoscopic)
- Procedure fee (Grade 3A hospital, inpatient): ¥4,200–0 ($588–$952) - Post-op rehabilitation (3 sessions): ¥450–¥63–$88)
- •Tumor resection (for paraneoplastic neuropathy)
- Surgical fee (neurosurgery/oncology department): ¥18,000–¥32,000 (
0–$4,480)Special / Complex Condition Management
- •
Quick Selection Guide
- •<60 years, immune-mediated, moderate disability, no comorbidities: IVIG + EMG monitoring ($1,792–$2,688 total)
- •>75 years, diabetic, mild pain, limited budget: Duloxetine + B12 supplementation ($76–$126/month)
- •Working-age patient, carpal tunnel + polyneuropathy, functional impairment: Carpal tunnel release + gabapentin ($667–$1,120 total)
- •ICU survivor with progressive weakness: Multidisciplinary rehab + ICU follow-up ($392–$630/day × 7–14 days)
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Polyneuropathy Medical Vacation Packages
Curated transparent all-inclusive packages combining Polyneuropathy treatment with China top medical destinations:
